YAP1 suppression inhibits autophagy and improves the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma

Yuting Gao(Xi'an Institute of Optics and Precision Mechanics), Xinli Shi(Shanxi University), Yu Xue(Dalian Medical University), Junlan Lu(Shanxi University), Yiwei Liu(Hebei University of Chinese Medicine), Shenghao Li(Hebei Medical University), Yi Gong(Ministry of Agriculture and Rural Affairs), Kangning Zheng(Chengdu University of Traditional Chinese Medicine), Yuman Zhang(Hebei University of Chinese Medicine), Qing Peng(Peking University)
Experimental Cell Research
January 21, 2023
10.1016/j.yexcr.2023.113486
Cited by 17

Related Papers

Bclaf1 is an important NF-κB signaling transducer and C/EBPβ regulator in DNA damage-induced senescence
|Cell Death and Differentiation|2016|80
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
|Journal of Inflammation Research|2024|61
S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer
|Molecular Cancer|2022|57
The current status and future of PD-L1 in liver cancer
|Frontiers in Immunology|2023|55
Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70
|Phytomedicine|2018|52